Expressing the isolated SH3 domains would help avoid potential off-target effects that might increase calcium entry, particularly in tissues like the heart, where decreased CaV1.2 inactivation has been linked to pathologies such as arrhythmias and heart failure. Here, CACNA1C is linked to heart failure.